Clinical Study
Influence of APOE Genotype on Alzheimer’s Disease CSF Biomarkers in a Spanish Population
Table 1
Demographic, clinical, and genetic characteristics of the study population.
| | MCI patients | Control subjects | Significance level |
| Number of cases | 29 | 27 | n.s. | Gender, male (%) | 38 | 44 | n.s. | Age (mean ± SD) | 70.34 ± 7.3 | 68.74 ± 7.5 | n.s. | Medical history | | | | HTA | 16 | 17 | — | DM | 2 | 8 | HPL | 17 | 18 | Depression | 7 | 6 | MMSE Folstein | 24 ± 0.8 | 28.48 ± 2.5 | 0.05 | IQCODE | 82.89 ± 3.5 | 52.62 ± 14.9 | 0.01 | Progression at 2 years | | | | Stable normal | — | 22 | — | Stable MCI | 17 | — | Develop MCI | — | 3 | Develop AD | 12 (, ) | 2 (, ) | APOE genotype | | | ε2 | 2 | 8 | ε3 | 14 | 18 | ε4 | 13 | 1 | Education (years) | 5 | 6 | n.s. |
|
|
SD = standard deviation. HTA = hypertension. DM = diabetes mellitus. HPL = hyperlipidemia. MMSE = mini mental status examination. IQCODE = informant questionnaire on cognitive decline in the elderly. MCI = mild cognitive impairment. AD = Alzheimer’s disease.
|